Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check37 days agoChange Detected- The site revision label was updated from v3.4.2 to v3.4.3. No study data or page content were changed.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice and the v3.4.1 revision note; study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedThe page now displays a government funding notice about potential delays and site operation status, and the revision badge was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a 'Show glossary' option on the page; capitalization tweaks were applied to QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). The revision was bumped from v3.3.4 to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.